Venture_Socks_RZ_RGB_300dpi(2)_edited.pn
icon-prizes.png

WINNERS

orange arrows.png

GlycoVaxyn

2004

Health & Nutrition

2000_W1_Carbofix.png
Sensirion_edited.jpg

GlycoVaxyn utilized its biological conjugation platform to develop next-generation bioconjugate vaccines against bacterial infections.